Skip to main content

Thermo Fisher Scientific Value Stock - Dividend - Research Selection

Thermo fisher scientific

ISIN: US8835561023 , WKN: 857209

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide. Its Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of new drugs and vaccines, as well as diagnosis of diseases to pharmaceutical, biotechnology, agricultural, clinical, academic, and government markets. Its Analytical Instruments segment offers instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and research and industrial markets, as well as clinical laboratories. Its Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; blood-test systems; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; products for cancer diagnosis and medical research in histology, cytology, and hematology; human leukocyte antigen typing and testing for organ transplant market; and healthcare market channel products. This segment serves healthcare, clinical, pharmaceutical, industrial, and food safety laboratories. Its Laboratory Products and Services segment offers laboratory refrigerators and freezers, ultralow-temperature freezers and cryopreservation storage tanks, temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis and laboratory equipment; laboratory plastics; laboratory chemicals; research and safety market channel; and pharma services. The company was founded in 1956 and is headquartered in Waltham, Massachusetts.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


The Broyhill Q1 2026 Portfolio Strategy And Positioning

2026-05-15
Broyhill Asset Management details its Q1 2026 performance and portfolio shifts, highlighting major contributors and new positions. Read the full analysis for more details.

Nuvation Bio to Collaborate with Thermo Fisher Scientific for U.S.-Based Manufacturing of IBTROZI® for ROS1-Positive Non-Small Cell Lung Cancer

2026-05-13
Nuvation Bio Inc. (NYSE: NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today announced the successful completion of process tech transfer and product introduction to Thermo Fisher Scientific, the world leader in serving science, for IBTROZI® (taletrectinib) to treat advanced or metastatic ROS1-positive (ROS1+) non-small cell lung cancer (NSCLC). The transition was submitted as a supplement to the IBTROZI New Drug Application held by Nuv

Nucleic Acid Isolation and Purification Market Report 2026-2030: Trends, Challenges and Competitive Analysis Featuring Thermo Fisher Scientific, Merck, QIAGEN, and Roche

2026-05-12
Nucleic Acid Isolation and Purification Market Nucleic Acid Isolation and Purification Market Dublin, May 12, 2026 (GLOBE NEWSWIRE) -- The "Nucleic Acid Isolation and Purification Market by Product, Method, Type, Application, End User, Region - Global Forecast to 2030" has been added to ResearchAndMarkets.com's offering.The nucleic acid isolation and purification market is poised for significant growth, projected to expand from USD 7.10 billion in 2025 to USD 10.99 billion by 2030, at a CAGR of

The Retirement Playbook Is Breaking - And Few Investors Are Ready

2026-05-12
Traditional 60/40 portfolios are riskier amid inflation and deficits. Read here for more on the biggest financial dangers for retirees and ways to overcome them.

Tracking William Von Mueffling's Cantillon Capital Management Portfolio - Q1 2026 Update

2026-05-11
Cantillon Capital Management’s Q1 2026 13F portfolio value declined to $15.05B. Click here to read more about the portfolio.

Thermo Fisher Expands Cell Therapy And Hydration Platforms To Deepen Ecosystem

2026-05-11
Thermo Fisher Scientific (NYSE:TMO) has introduced the Gibco CTS DynaXS Single Use Bioreactor, targeting cell therapy manufacturing. The company has opened its flagship U.S. Bioprocess Design Center in Massachusetts to support biologics and advanced therapy development. Thermo Fisher is a top vendor in the growing DNA synthesis market and is expanding its Nalgene Outdoor hydration product line. Thermo Fisher Scientific, with a current share price of $465.0, operates at the intersection of...

DNA Synthesis Market to Reach $30.4 billion, Globally, by 2035 at 18.2% CAGR: Allied Market Research

2026-05-11
DNA synthesis technologies, supported by automated synthesizers, high-throughput platforms, oligonucleotide production systems, gene assembly tools, and AI-driven design software, allow researchers to create precise and custom DNA sequences for a wide range of applications. Leading providers such as Thermo Fisher Scientific Inc., Twist Bioscience, and GenScript Biotech Corporation are continuously enhancing synthesis accuracy, scalability, and turnaround time through technological innovation.

Nalgene Outdoor Introduces Fresh Flow Straw Bottle

2026-05-11
Nalgene Outdoor introduced the Fresh Flow straw bottle, a new addition to its reusable bottle collection designed to give fans more ways to hydrate without sacrificing the simplicity, durability, and...

Thermo Fisher Scientific : Additional Soliciting Materials

2026-05-11
THERMO FISHER SCIENTIFIC INC. Supplemental Information Regarding Proposal 2: Advisory Vote to Approve Executive Compensation Commencing on May 11, 2026, Thermo...

Jim Cramer on Thermo Fisher: “I Think You Can Buy It at This Level”

2026-05-09
Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the stocks Jim Cramer shared his thoughts on as he discussed Big Tech’s AI spending. A caller asked whether the stock is a buy, sell, or hold. In response, Cramer said: I like it here. I see so many IPOs every morning that Carl mentions, and they’re […]